MT-601
MRKR-22-601-01
Phase 1 small_molecule active
Quick answer
MT-601 for Non-Hodgkin Lymphoma, Adult is a Phase 1 program (small_molecule) at Marker Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Marker Therapeutics
- Indication
- Non-Hodgkin Lymphoma, Adult
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active